Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetic Properties of Liraglutide as Adjunct to Insulin in Subjects with Type 1 Diabetes Mellitus ; day:9 ; month:6 ; year:2016 ; pages:1-7
Clinical pharmacokinetics ; (9.6.2016), 1-7
- Creator
-
Mader, Julia K.
- Contributor
-
JENSEN, LENE
Ingwersen, Steen H.
Christiansen, Erik
Heller, Simon
Pieber, Thomas R.
SpringerLink (Online service)
- DOI
-
10.1007/s40262-016-0413-4
- URN
-
urn:nbn:de:1111-201606111203
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mader, Julia K.
- JENSEN, LENE
- Ingwersen, Steen H.
- Christiansen, Erik
- Heller, Simon
- Pieber, Thomas R.
- SpringerLink (Online service)
Other Objects (12)
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Effects of liraglutide on abdominal fat distribution and glucose metabolism in Chinese subjects with obesity
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Effects of liraglutide on abdominal fat distribution and glucose metabolism in Chinese subjects with obesity
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects
Pharmacokinetic and Safety Study of Bismuth Potassium Citrate Formulations in Healthy Subjects
Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
Pharmacometabolomic profiles in type 2 diabetic subjects treated with liraglutide or glimepiride
A Comparison of Pharmacokinetic and Pharmacodynamic Properties Between Faster-Acting Insulin Aspart and Insulin Aspart in Elderly Subjects with Type 1 Diabetes Mellitus
Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
Population Pharmacokinetic Analysis of Rivipansel in Healthy Subjects and Subjects with Sickle Cell Disease
Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
Effect of Liraglutide on Type B Insulin Resistance Syndrome and Insulin Allergy in Type 2 Diabetes: A Case Report
Effects of liraglutide on abdominal fat distribution and glucose metabolism in Chinese subjects with obesity
Retrospective Analysis of an Insulin-to-Liraglutide Switch in Patients with Type 2 Diabetes Mellitus
Pharmacokinetic and Pharmacodynamic Equivalence of Pegfilgrastim-cbqv and Pegfilgrastim in Healthy Subjects
Pharmacokinetic interactions of esaxerenone with amlodipine and digoxin in healthy Japanese subjects